Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 4, Avril 2002
Page(s) 422 - 424
Section Le Magazine : Derniére Heure
DOI http://dx.doi.org/10.1051/medsci/2002184422
Publié en ligne 15 avril 2002
  1. Krammer P. CD95’s deadly mission in the immune system. Nature 2000; 407 : 789–95.
  2. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of theFas ligand in the development of hepatitis. Nat Med 1997; 3 : 409–13.
  3. Janin A, Deschaumes C, Daneshpouy M, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 2002; 99 : 2940–7.
  4. D’Souza SD, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996; 184 : 2361–70.
  5. Su X, Hu Q, Kristan JM, et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 2000; 164 : 2523–32.
  6. Ameisen JC. Apoptosis subversion: HIV-Nef provides both armor and sword. Nat Med 2001; 7 : 1181–2.
  7. Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000; 106 : 25–35.
  8. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282 : 490–3.
  9. Zeytun A, Nagarkatti M, Nagarkatti PS. Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas+ organs. Blood 2000; 95 : 2111–7.
  10. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effects of the anti-Fas antibody in mice. Nature 1993; 364 : 806–9.
  11. Lacronique V, Mignon A, Fabre M, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996;2 : 80–6.
  12. Huang DCS, Hahne M, Schroeter M, et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-XL. Proc Natl Acad Sci USA 1999; 96 : 14871–6.
  13. Kaplan H, Leibole M, Tezel T, Ferguson T. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 1999; 5 : 292–7.
  14. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumu S, et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186 : 1831–41.
  15. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293 : 293–7.
  16. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative caspase 8-independent cell death pathway using kinase RIP as effector molecule. Nat Immunol 2000; 1 : 489–95.
  17. Kerbel R. A cancer therapy resistant to resistance. Nature 1997; 390 : 335–6.
  18. Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000; 6 : 920–3.